Sfoglia per AUTORE
ON BEHALF OF THE ITALIAN MELANOMA INTERGROUP IMI STUDY
Collezione AO Cuneo
Items : 1
No Impact of NRAS Mutation on Features of Primary and Metastatic Melanoma or on Outcomes of Checkpoint Inhibitor Immunotherapy: An Italian Melanoma Intergroup (IMI) Study. in Cancers / Cancers (Basel). 2021 Jan 26;13(3):475. doi: 10.3390/cancers13030475.
2021
AO Cuneo
AO Cuneo
Ascierto PA; Chiaron Sileni V; Gambale E; Quaresmini D; De Risi I; Queirolo P; Ridolfi L; Occelli M; Spagnolo F; Tucci M; Minisini AM; Di Giacomo AM; Pigozzo J; Quaglino P; Madonna G; Bartolomeo N; Guida M; Stigliano L; Strippoli S; On Behalf Of The Italian Melanoma Intergroup Imi Study;